Outsourcing-pharma21h
Senhwa Biosciences starts trial of silmitasertib in children with difficult to treat cancers
The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...
Outsourcing-pharma21h
Novo Nordisk signs $285 million deal for a once-monthly GLP-1 receptor agonist
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Outsourcing-pharma2d
Palomar Health inspires youth with hands-on medical program
Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.
Outsourcing-pharma2d
Starget Pharma’s AI-Driven Cancer Therapy Gains $5.1 Million Backing
Innovative radiotherapy offers a precision treatment alternative.
Outsourcing-pharma3d
Novo Nordisk’s semaglutide shows additional cardiovascular benefits in overweight patients
Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...
Outsourcing-pharma4d
Streamlining early phase drug development with continuous flow technologies
Lonza’s innovative continuous flow technology and mini-monoplant approach are transforming early-phase drug development. How ...
Outsourcing-pharma6d
Top 10 rare disease pharma sees 10.4% rise in therapy start
A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% ...
Outsourcing-pharma3d
FDA grants accelerated approval to Novartis’ Scemblix as a first-line leukemia therapy
Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.
Outsourcing-pharma3d
Thermo Fisher integrates Labguru ELN for streamlined lab management
Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations ...